About the Programme:

The course will give knowledge aboutPatenting and Licensing of Stem Cell Technologies.

Patenting and licensing of stem cell technologies can provide a financial incentive for researchers and companies to invest time and resources into developing new stem cell-based therapies, leading to the discovery of new treatments for diseases.

Allows researchers and companies to protect their intellectual property rights, which can provide an exclusive right to commercialize and market the technology, and help recoup the costs of research and development.  Licensing agreements can facilitate collaboration between stem cell researchers and companies, enabling the sharing of technology and know-how, and fostering the development of new stem cell-based therapies.

It helps to ensure that stem cell-based therapies are developed and commercialized in compliance with regulatory requirements, promoting patient safety and public trust.

It can lead to the development of new stem cell-based therapies, which can improve patient outcomes and quality of life for those suffering from various diseases.

It can promote economic growth by stimulating investment, creating jobs, and generating revenues for stem cell research institutions and companies.

Objectives of the program:

• Provides researchers and companies with a financial incentive to invest in research and development of new stem cell-based therapies, by allowing them to protect their innovations and potentially earn a return on their investment.
• Enables stem cell researchers and companies to protect their intellectual property rights, which encourages investment in and development of stem cell technologies, and promotes technology transfer.
• Facilitates the commercialization of new stem cell-based therapies, by providing exclusive rights to commercialize and market the technology, and thereby generate profits to support further research and development.
• Ensure that stem cell-based therapies are developed and commercialized in a safe and ethical manner, by enabling regulatory agencies to establish and enforce safety and ethical standards.

Topics to be covered:

• Types of stem cells
• Licensing agreements
• Technology transfer
• Regulatory compliance
• Business development

Programme Committee:

Chief Patron

Chairman

Dr. P. Rajeshwar Reddy

M.Sc, Ph.D.

Secretary and Correspondent

Patron

Dr. M. Chinna Eswaraiah,

M. Pharm, Ph.D.

Principal

Convener

Dr. S. Jaya,

M. Pharm, Ph.D.

Professor

Department of Pharmaceutics

Email ID: jayamay21@gmail.com

Contact number: 9908778846

Coordinator

Mr. K. Raveendra Babu

M. Pharm,

Assistant Professor

Department of Pharmaceutics

Email ID: ravipharma36@gmail.com

Contact number: 99592 12028

Resource Person:

Mr. B. Ravi,

M. Pharm,

Assistant Professor,

Department of Pharmacology,

Swami Ramananda Tirtha Institute of Pharmaceutical Sciences, Nalgonda, Telangana.

E Mail id: badhavathravi369@gmail.com

Contact number: 9573717946

Address for Communication:

Mr. D. Chinnababu

M. Pharm

Assistant Professor

Department of Pharmaceutics

Email ID:devapanguchinnababu@gmail.com

Contact number: 9703235929

Last date to Registration: 01/08/2019